Skip to content ↓

Topic

Bacteria

Download RSS feed: News Articles / In the Media

Displaying 16 - 30 of 83 news clips related to this topic.
Show:

Forbes

Writing for Forbes, Jeff Kart highlights how MIT researchers have developed a new technique to process samples of bacteria and gauge whether the bacteria can produce electricity. “The vision is to harness the most-powerful bacteria for tasks like running fuel cells or purifying sewage water,” Kart explains.

Guardian

Guardian reporter Ian Sample writes that MIT startup Synlogic are developing a “living” medicine” made from genetically modified bugs. “By engineering these bacteria, we are able to control how they operate in the human gastrointestinal tract,” says Caroline Kurtz of Synlogic. “It allows us to think about many other diseases where you may need to produce something beneficial, or remove something that is toxic for the patient.”

Guardian

MIT researchers have engineered wasp venom to kill bacteria, reports Chukwuma Muanya for The Guardian. The researchers found that the altered peptides wiped out the antibiotic-resistant bacteria Pseudomonas aeruginosa within four days.

Forbes

Forbes reporter Fiona McMillan writes that MIT researchers have engineered an anti-bacterial peptide found in wasp venom in an effort to create a new antibiotic. McMillan writes that the researchers, “gained new insight into which structural attributes work best, either alone or in combination. In this way, they were able to tweak the peptide’s structure to obtain optimal function.”

Xinhuanet

MIT researchers have repurposed the toxic venom found in wasps to create a new drug that could potentially be used to kill bacteria, reports the Xinhua news agency. “The venom-derived peptide is believed to kill microbes by disrupting bacterial cell membranes,” Xinhua explains.

Boston Herald

Boston Herald reporter Jordan Graham writes that MIT researchers have used the venom from a South American wasp to engineer a new type of antibiotic. “The idea here is to take that very well-crafted toxin and turn it into something that can be useful for humans and our society,” explains César de la Fuente Nunez, a postdoc at MIT.

Science

Science reporter Tania Rabesandratana examines how MIT researchers are gathering and identifying gut bacteria from people around the world. The effort is aimed at preserving the human gut’s microbial biodiversity and developing new treatments for diseases. “I'm 100% confident that there are relevant medical applications for hundreds of strains we've screened and characterized,” explains Prof. Eric Alm.

Stat

STAT reporter Orly Nadell Farber writes about a new study by MIT researchers that shows glaucoma might be caused by T-cells, an integral component of the human body’s immune system, attacking retinal cells. Farber explains that, “this discovery could unlock a critical new door for treatment options.”

United Press International (UPI)

A new study by MIT researchers provides evidence that glaucoma may be caused by an autoimmune disease, according to a HealthDay News piece published by UPI. “Further research will try to determine whether other parts of the immune system play a role in glaucoma, and whether autoimmunity is a factor in degenerative brain diseases.”

Boston Globe

Boston Globe reporter Jonathan Saltzman writes about how MIT alumnus Bernat Olle’s startup, Vedanta Biosciences, Inc., is looking to “collect a sample of every type of bacteria that lives in the gut.” The hope is to one day use what’s learned from this ‘library’ to help treat diseases.

The Boston Globe

MIT researchers have discovered that probiotics can prevent cholera and treat early stage cases of the disease, reports Laney Ruckstuhl for The Boston Globe. The findings, led by Prof. James Collins, “could have implications for other diseases as well because scientists were previously unaware that bacterial infections could be vulnerable to naturally occurring probiotics,” notes Ruckstuhl.

CNBC

CNBC reporter Thomas Catenacci writes that researchers at the MIT Design Lab are collaborating with Puma to develop a new shoe made with bacteria that can react to how the wearer is feeling. They presented their ‘biodesigns’ at Milan Design Week, notes Catenacci, explaining that the shoe’s material can learn “a user's specific heat patterns and opens up ventilation based on those user-specific heat patterns.”

Los Angeles Times

Using specially engineered E. coli bacteria and electronics that fit into an ingestible pill, MIT researchers have created a device that can detect internal diseases and send wireless alerts, reports Karen Kaplan for The Los Angeles Times. The device could eliminate the need for colonoscopies, which alter “the physiology inside the intestines, potentially masking signs of disease,” explains Kaplan.

USA Today

USA Today reporter Sean Rossman writes about how MIT researchers have created an ingestible sensor that can monitor the digestive tract and send information to a smartphone or tablet about a person’s health. Rossman explains that the device, “can detect blood in the stomach, something that would otherwise require an endoscopy and sedation.”

Associated Press

MIT researchers have developed an ingestible capsule that uses genetically engineered bacteria to detect potential health problems, reports Carla Johnson for the Associated Press. The researchers hope the capsule could eventually be used to, “find signs of ulcers, inflammatory bowel disease or even colon cancer.”